You are Trying to View a Free Article
Daily News You Can't Find Anywhere ElseJ&J Taps Merck Plant in Durham, North Carolina, for COVID-19 Vaccine Production, an Industrial Info Market Brief
Industry Segment: Market Brief | Word Count: 92 Words
Attachment: A
Merck's Maurice R. Hillman Center for Vaccine Manufacturing in Durham (Treyburn), NC is on board to help with boosting production of Johnson & Johnson's COVID-19 vaccine. The plant will provide the bulk drug substance (biological active pharmaceutical ingredient) for the drug.
One of two plants designated to help produce the drug, the Durham facility has $800 million in active capital expansion projects.
Subscribe Now! All Fields Required...
Related Articles
- Central Asia Home For $762.8 Million in Glass Manufacturing Projects, an In...
- Central Asia Home For $762.8 Million in Glass Manufacturing Projects, an In...
- Algeria's Groupement TouatGaz Proceeds with Second-Phase Development, an In...
- Diamond Production in Africa to Increase in 2021, an Industrial Info Market...
- Europe Set for $240 Million in Pulp, Paper, Wood Maintenance through End of...
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker
All Members Receive the Following Free Resources:
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
